Europe Gene Vector Market Size & Outlook, 2025-2033
Related Markets
Europe gene vector market highlights
- The Europe gene vector market generated a revenue of USD 2,311.1 million in 2024.
- The market is expected to grow at a CAGR of 19.9% from 2025 to 2033.
- In terms of segment, viral vectors was the largest revenue generating type in 2024.
- Non-Viral Vectors is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2033.
Europe data book summary
| Market revenue in 2024 | USD 2,311.1 million |
| Market revenue in 2033 | USD 11,562.4 million |
| Growth rate | 19.9% (CAGR from 2025 to 2033) |
| Largest segment | Viral vectors |
| Fastest growing segment | Non-Viral Vectors |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Viral Vectors, Non-Viral Vectors |
Other key industry trends
- In terms of revenue, Europe region accounted for 29.3% of the global gene vector market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 11,506.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Gene Vector Market Scope
Gene Vector Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Eurofins Genomics | View profile | 251-500 | Huntsville, Alabama, United States, North America | https://www.eurofinsgenomics.co.in/ |
| Luminous BioSciences | View profile | 251-500 | Gaithersburg, Maryland, United States, North America | https://www.luminousbio.com |
| VGXI | View profile | 101-250 | The Woodlands, Texas, United States, North America | https://vgxii.com/ |
| Kaneka Corp | View profile | 13284 | 3-2-4, Nakanoshima, Kita-ku, Osaka, Japan, 530-8288 | http://www.kaneka.co.jp |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
Europe gene vector market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene vector market will help companies and investors design strategic landscapes.
Viral vectors was the largest segment with a revenue share of 63.22% in 2024. Horizon Databook has segmented the Europe gene vector market based on viral vectors, non-viral vectors covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Europe gene vector market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe gene vector market databook
-
Our clientele includes a mix of gene vector market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe gene vector market , including forecasts for subscribers. This continent databook contains high-level insights into Europe gene vector market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Europe gene vector market size, by country, 2021-2033 (US$M)
Europe Gene Vector Market Outlook Share, 2024 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
